Drug
Tocilizumab
Tocilizumab: highest development phase Phase 3, developed by Dr. Reddy's, Roche. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Dr. Reddy's, Roche
Trials
| Drug | Phase | Indication |
|---|---|---|
| Tocilizumab NCT03155347 | Phase 3 | Rheumatoid Arthritis |
| Tocilizumab Prefilled Syringe NCT04885829 | Phase 1 | Rheumatoid Arthritis |
Latest
No recent events.
Follow Tocilizumab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.